Skip to main content
OpenTrials
Completed

NCT Number: NCT07711782

Management of Polycystic Ovarian Syndrome-associated Reproductive Dysfunction Through Kefir Supplementation

Polycystic ovary syndrome (PCOS) affect around 6-12% of women of age 18-25 years. Kefir contains bioactive compounds such as lactic acid bacteria, yeast, peptides, polysaccharides and organic acids and acts as a good probiotic source.

Completed

Looking for future studies?

Notify Me

Key information

About this study

The target population were females between the ages of 18 and 25 years who have the history of amenorrhea or delayed periods, unusual weight gain, cyst in their ovaries, hormonal imbalance or thyroid issue. Once consent is given, participants were then be randomly assigned to receive the prescribed intervention or act as a control.

(C0) Control group: Participants were only be subjected to use a regular calorie deficit diet plan (G1) Experimental group: Participants were advised to take water 250ml of water kefir per day in their mid-morning snack time for 2 months.

At baseline, nutritional assessment based on weight and height, BMI, waist circumference, blood pressure, fasting blood glucose, lipid panels (HDL, LDL, total cholesterol, triglycerides), FHS Levels, LH levels, TSH levels was done after 8 weeks of intervention.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Females of age 18-25 will be selected.
  • Females suffering from amenorrhea or cycle longer then 35days were selected.
  • Females with PCOS were selected.
  • Females with BMI 18.5-29.9 were selected in this research.
  • Females with thyroid issues were selected.

Exclusion criteria

  • Pregnant and breast-feeding females were not included.
  • Those who smoke were not included.
  • Those who consume alcohol were not included.
  • Those suffering from endocrine diseases were not be included.
  • Those taking lipid- lowering drugs or blood pressure regulating medications were not be included.
  • Those taking antibiotics or medications related to PCOS treatment or vitamin-mineral or probiotics within 1 month prior to study inclusion.

Treatment and study plan

(C0) Control group

Other

Participants were subjected to use a regular calorie deficit diet plan

(G1) Experimental group

Dietary Supplement

Participants were advised to take water 250ml of water kefir per day in their mid-morning snack time for 2 months.

Primary outcomes

  1. Lipid Profile

    Time frame: 8 weeks

    Blood lipid profile were obtained using fasting blood samples to determine serum total cholesterol, high-density lipoprotein cholesterol (HD L-C), low density lipoprotein cholesterol (LDL-C) and triglycerides.

Secondary outcomes

  1. FSH (follicle stimulating hormone)

    Time frame: 8 weeks

    Blood test will be done to check the reproductive health

  2. LH (luteinizing hormone)

    Time frame: 8 weeks

    Blood test to check the secretion of luteinizing hormone and how it triggers ovulation and stimulate testosterone production.

Other outcomes

  1. TSH (Thyroid stimulating hormone test)

    Time frame: 8 weeks

    Blood test were done to monitor the levels of TSH.

Sponsors and collaborators

Lead sponsor

University of Lahore

Other

Registry information

Official study title

Managing Polycystic Ovarian Syndrome- Associated Reproductive Dysfunction Through Kefir Supplementation

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Jul 17, 2026
Registry last updated
Jul 17, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.